Home Cart Sign in  
Chemical Structure| 1691249-45-2 Chemical Structure| 1691249-45-2

Structure of Zanubrutinib
CAS No.: 1691249-45-2

Chemical Structure| 1691249-45-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Zanubrutinib is a selective Bruton tyrosine kinase (BTK) inhibitor.

Synonyms: BGB-3111

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Zanubrutinib

CAS No. :1691249-45-2
Formula : C27H29N5O3
M.W : 471.55
SMILES Code : O=C(C1=C2NCC[C@@H](C3CCN(C(C=C)=O)CC3)N2N=C1C4=CC=C(OC5=CC=CC=C5)C=C4)N
Synonyms :
BGB-3111
MDL No. :MFCD31567461
InChI Key :RNOAOAWBMHREKO-QFIPXVFZSA-N
Pubchem ID :135565884

Safety of Zanubrutinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Zanubrutinib

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04172246 Mature B-cell Malignancies PHASE1|PHASE2 ACTIVE_NOT_RECRUITING 2025-06-30 Nagoya University Hospital, Na... More >>goya, Aichi, 466-8560, Japan|Toyohashi Municipal Hospital, Toyohashi, Aichi, 441-8570, Japan|Chiba Cancer Center, Chibashi, Chiba, 260-8717, Japan|Matsuyama Red Cross Hospital, Matsuyamashi, Ehime, 790 8524, Japan|Kurume University Hospital, Kurume, Fukuoka, 830-0011, Japan|National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido, 003-0804, Japan|Aiiku Hospital, Sapporo, Hokkaido, 064-0804, Japan|Kobe City Medical Center General Hospital, Kobe, Hyogo, 650-0047, Japan|Kanagawa Cancer Center, Yokohamashi, Kanagawa, 241-8515, Japan|National Cancer Center Hospital, Chuoku, Tokyo, 104-0045, Japan|Aomori Prefectural Central Hospital, Aomori, 030-8553, Japan|Gifu Municipal Hospital, Gifu, 500-8513, Japan|The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, 852-8511, Japan|National Hospital Organization Okayama Medical Center, Okayama, 701-1192, Japan|Yokohama Municipal Citizens Hospital, Yokohamashi, 221-0855, Japan Less <<
NCT06341556 Mantle Cell Lymphoma|Maintenan... More >>ce Therapy Less << PHASE2 RECRUITING 2025-06-28 Fudan University Shanghai Canc... More >>er Center, Shanghai, Shanghai, 200032, China|Shanghai Cancer Center, Shanghai, Shanghai, 200032, China Less <<
NCT05767398 Healthy Volunteers PHASE1 COMPLETED 2023-04-28 Fortrea Clinical Research Unit... More >>, Dallas, Texas, 75247, United States Less <<
NCT05214391 Immune Thrombocytopenia|Treatm... More >>ent Less << PHASE2 UNKNOWN 2024-06-30 Chinese Academy of Medical Sci... More >>ence and Blood Disease Hospital, Tianjin, Tianjin, 300020, China Less <<
NCT03465059 Hepatic Insufficiency & Health... More >>y Subjects Less << PHASE1 COMPLETED 2018-10-19 University of Miami, Miami, Fl... More >>orida, 33124, United States|Orlando Clinical Research Center, Orlando, Florida, 32809, United States Less <<
NCT04116437 Chronic Lymphocytic Leukemia/S... More >>mall Lymphocytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia Less << PHASE2 ACTIVE_NOT_RECRUITING 2025-10-25 Arizona Oncology Associates, P... More >>c Hope, Tucson, Arizona, 85711, United States|Rocky Mountain Cancer Centers (Williams) Usor, Aurora, Colorado, 80012, United States|Christiana Care, Newark, Delaware, 19713, United States|Scri Florida Cancer Specialists South, Fort Myers, Florida, 33901, United States|St Century Oncology, Jacksonville, Florida, 32204, United States|Mid Florida Hematology and Oncology Center, Orange City, Florida, 32763, United States|Scri Florida Cancer Specialists North, Saint Petersburg, Florida, 33705, United States|Healthcare Research Network Iii, Llc, Tinley Park, Illinois, 60487, United States|Minnesota Oncology Burnsville Clinic, Burnsville, Minnesota, 55337, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Summit Medical Group, Florham Park, New Jersey, 07932, United States|Morristown Medical Center, Morristown, New Jersey, 07960, United States|Clinical Research Alliance, Inc, Westbury, New York, 11590, United States|Oncology Associates of Oregon Willamette Valley Cancer Center, Eugene, Oregon, 97401, United States|St Lukes University Health Network, Bethlehem, Pennsylvania, 18015, United States|Abington Hematology Oncology Associates, Horsham, Pennsylvania, 19044, United States|Tennessee Oncology, Pllc Nashville, Nashville, Tennessee, 37203, United States|Texas Oncology Amarillo, Amarillo, Texas, 79106, United States|Baylor Research Institute, Dallas, Texas, 75246, United States|Texas Oncology McAllen South Second Street, McAllen, Texas, 78503, United States|Texas Oncology Tyler Longview, Tyler, Texas, 75702, United States|Us Oncology Virginia Cancer Specialists, Pc, Fairfax, Virginia, 22031, United States|Virginia Oncology Associates Hampton, Virginia Beach, Virginia, 23456, United States|Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, United States|Medical Oncology Associates, Spokane, Washington, 99208, United States|Ssm Health Cancer Care Dean Medical Center, Madison, Wisconsin, 53717, United States Less <<
NCT05596097 Diffuse Large B-cell Lymphoma ... More >>(DLBCL) Less << PHASE2 NOT_YET_RECRUITING 2026-07-30 The First Hospital of Lanzhou ... More >>University, Lanzhou, Gansu, 730000, China Less <<
NCT05640102 Waldenstrom Macroglobulinemia RECRUITING 2025-12-27 Clearview Cancer Institute, Hu... More >>ntsville, Alabama, 35805, United States|Mitchell Cancer Institute, Mobile, Alabama, 36604, United States|City of Hope National Medical Center, Duarte, California, 91010, United States|Los Angeles Cancer Network (Lacn), Glendale, California, 91204, United States|Valkyrie Clinical Trials, Los Angeles, California, 90067, United States|Eisenhower Medical Center, Lucy Curci Cancer Center, Rancho Mirage, California, 92270, United States|Pacific Central Coast Health Centers, Slo Oncology and Hematology Health Center, San Luis Obispo, California, 93401, United States|Pacific Central Coast Health Centers, Mission Hope Medical Oncology, Santa Maria, California, 93454, United States|Brcr Medical Center, Inc, Plantation, Florida, 33322, United States|Tulane Cancer Center, New Orleans, Louisiana, 70112, United States|Hattiesburg Hematology and Oncology Clinic, Hattiesburg, Mississippi, 39401, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Summit Medical Group, Florham Park, New Jersey, 07932, United States|Morristown Medical Center, Morristown, New Jersey, 07960, United States|Clinical Research Alliance, Inc, Westbury, New York, 11590, United States|Pan American Oncology Trials, Llc, Rio Piedras, 00935, Puerto Rico|Auxilio Mutuo Cancer Center, San Juan, 00917, Puerto Rico Less <<
NCT06021977 Refractory/Relapsed Autoimmune... More >> Hemolytic Anemia Less << PHASE2 RECRUITING 2025-12-31 Regenerative Medicine Center, ... More >>Tianjin, Tianjin, 300131, China Less <<
NCT04743687 Idiopathic Multicentric Castle... More >>man's Disease Less << PHASE2 UNKNOWN 2025-01-01 Peking Union Medical College H... More >>ospital, Beijing, Beijing, 100005, China Less <<
NCT04163523 Healthy Volunteers PHASE1 COMPLETED 2016-07-21 Cancer Care Wollongong, Wollon... More >>gong, New South Wales, 2500, Australia|Austin Health, Heidelberg, Victoria, 3084, Australia|Peter Maccallum Cancer Centre, Melbourne, Victoria, 3000, Australia|Nucleus Network, Melbourne, Victoria, 3004, Australia|Linear Clinical Research, Nedlands, Western Australia, 6009, Australia Less <<
NCT03332173 Waldenstr?m's Macroglobulinemi... More >>a (WM) Less << PHASE2 COMPLETED 2021-01-11 Cancer Hospital Chinese Academ... More >>y of Medical Sciences, Beijing, Beijing, 100021, China|Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|Guangdong Provincial Peoples Hospital, Guangzhou, Guangdong, 510080, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Affiliated Hospital of Soochow University Branch Shizi, Suzhou, Jiangsu, 215006, China|Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China|West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China Less <<
NCT05068440 Relapsed Diffuse Large B-cell ... More >>Lymphoma|Refractory Diffuse Large B-cell Lymphoma Less << PHASE2 RECRUITING 2024-12-30 Anhui Provincial Cancer Hospit... More >>al Aka West Branch of Anhui Province Hospital, Hefei, Anhui, 230088, China|Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, 100050, China|Fujian Cancer Hospital, Fuzhou, Fujian, 350014, China|Sun Yat Sen University Cancer Center, Guangzhou, Guangdong, 510060, China|Guangdong Provincial Peoples Hospital Huifu Branch, Guangzhou, Guangdong, 510120, China|The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China|The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, China|Hainan Cancer Hospital, Haikou, Hainan, 570312, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, China|Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China|The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China|Hunan Cancer Hospital, Changsha, Hunan, 410013, China|The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi, 330006, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, 110042, China|Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China|Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, 030013, China|West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China|Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, 300020, China|Yunnan Cancer Hospital, Kunming, Yunnan, 650100, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|Zhejiang University College of Medicine Second Affiliated Hospital, Hangzhou, Zhejiang, 310009, China|Taizhou Hospital of Zhejiang, Taizhou, Zhejiang, 317000, China Less <<
NCT06441214 Waldenstr?m's Macroglobulinemi... More >>a (WM) Less << NOT_YET_RECRUITING 2025-07-26 A.O. SS. Antonio e Biagio e Ce... More >>sare Arrigo - S.C.D.U. Ematologia, Alessandria, Italy|A.O.U. Ospedali Riuniti - Clinica di Ematologia, Ancona, Italy|Ospedale C. e G. Mazzoni - U.O.C. di Ematologia, Ascoli Piceno, Italy|AOU Policlinico Consorziale - U.O. Ematologia con Trapianto, Bari, Italy|Nuovo Ospedale degli Infermi - SSD Ematologia, Biella, Italy|Policlinico S. Orsola-Malpighi - Istituto di Ematologia "Seragnoli", Bologna, Italy|Ospedale Centrale di Bolzano - Divisione di Ematologia e T.M.O., Bolzano, Italy|Azienda Ospedaliera Universitaria Policlinico - S. Marco - UOC di Ematologia, Catania, Italy|Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale Sant'Anna - Ematologia e fisiopatologia della coagulazione, Ferrara, Italy|Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia, Firenze, Italy|Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia e terapie cellulari, Genova, Italy|ASST Grande Ospedale Metropolitano Niguarda - S.C. Ematologia, Milano, Italy|IEO Istituto Europeo di Oncologia - Divisione Ematoncologia, Milano, Italy|Ospedale Maggiore Policlinico - Fondazione IRCCS Ca Granda - Ematologia, Milano, Italy|AOU Maggiore della Carità di Novara - SCDU Ematologia, Novara, Italy|AOU di Padova - Ematologia, Padova, Italy|A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia, Palermo, Italy|RCCS Policlinico S. Matteo di Pavia - Div. di Ematologia, Pavia, Italy|P.O. Spirito Santo di Pescara - UOC Ematologia Dipartimento Oncologico Ematologico - ASL Pescara, Pescara, Italy|AOU Pisana - U.O. Ematologia, Pisa, Italy|Ospedale delle Croci - Ematologia, Ravenna, Italy|Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia, Reggio Emilia, Italy|Università Cattolica Sacro Cuore - Ematologia, Roma, Italy|AOU Senese - U.O.C. Ematologia, Siena, Italy|Ospedale "G. Mazzini" - UOS Ematologia, Teramo, Italy|A.O.U. Città della Salute e della Scienza di Torino - Ematologia Universitaria, Torino, Italy|A.O.U. Città della Salute e della Scienza di Torino - S.C. Ematologia, Torino, Italy|Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - SOC Clinica Ematologica, Udine, Italy Less <<
NCT03206970 Refractory Mantle Cell Lymphom... More >>a|Relapsed Mantle Cell Lymphoma Less << PHASE2 COMPLETED 2020-09-08 Beijing Cancer Hospital, Beiji... More >>ng, Beijing, 100142, China|Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China|Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, 510515, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai, 200000, China|West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China|Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, 300020, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, 300060, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China Less <<
NCT05922839 Warm Autoimmune Hemolytic Anem... More >>ia Less << PHASE2 RECRUITING 2025-12-25 Peking Union Medical College H... More >>ospital, Beijing, Beijing, 100730, China Less <<
NCT05117814 CNS Lymphoma RECRUITING 2025-07-25 Peking University People's Hos... More >>pital, Beijing, Beijing, 100044, China Less <<
NCT02343120 B-cell Malignancies PHASE1|PHASE2 COMPLETED 2021-03-31 Banner MD Anderson Cancer Cent... More >>re, Gilbert, Arizona, 85234, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Mayo Clinic, Rochester, Minnesota, 55901, United States|M.D. Anderson Cancer Center, Houston, Texas, 77030, United States|Concord Repatriation General Hospital, Concord, New South Wales, Australia|St George Hospital, Sydney, New South Wales, Australia|Westmead Hospital, Westmead, New South Wales, Australia|Princess Alexandra Hospital, Brisbane, Queensland, Australia|Royal Hobart Hospital, Hobart, Tasmania, Australia|Monash Health, Clayton, Victoria, Australia|Austin Health, Heidelberg, Victoria, Australia|St Vincent's Hospital, Melbourne, Victoria, Australia|Peter MacCallum Cancer Centre, East Melbourne, Parkville, Victoria, 3050, Australia|Melbourne Health, Parkville, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Policlinico S.Orsola Malpighi, AOU di Bologna, Bologna, Italy|Ospedale Maggiore Policlinico, Fondazione IRCCS Ca' Granda, Milano, Italy|Dong-A University Medical Centre, Busan, Korea, Republic of|Inje University Busan Paik Hospital, Busan, Korea, Republic of|National Cancer Center, Goyang-si, Korea, Republic of|Samsung Medical Center, Seoul, Korea, Republic of|North Shore Hospital, Auckland, New Zealand|Derriford Hospital, Plymouth, Devon, United Kingdom Less <<
NCT03145064 Diffuse Large B-cell Lymphoma PHASE2 COMPLETED 2020-09-03 Beijing Cancer Hospital, Beiji... More >>ng, Beijing, 100142, China|Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|The First Affiliated Hospital of Soochow University Branch Shizi, Suzhou, Jiangsu, 215006, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|Fudan University Shanghai Cancer Center, Shanghai, Shanghai, 200000, China|Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, 200025, China|West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China|Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, 300020, China|Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, 300060, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China Less <<
NCT06489184 CLL NOT_YET_RECRUITING 2025-12-30 Peking University People's Hos... More >>pital, Beijing, Beijing, 100044, China Less <<
NCT05547399 Healthy Volunteers PHASE1 COMPLETED 2022-12-07 Fortrea Clinical Research Unit... More >>, Dallas, Texas, 75247, United States Less <<
NCT05279872 Immune Thrombocytopenia|Bruton... More >> Tyrosine Kinase Less << PHASE2 COMPLETED 2022-10-30 Peking University Insititute o... More >>f Hematology, Peking University People's Hospital, Beijing, Beijing, 100010, China Less <<
NCT03206918 Relapsed or Refractory Chronic... More >> Lymphocytic Leukemia|Relapsed or Refractory Small Lymphocytic Lymphoma Less << PHASE2 COMPLETED 2020-09-10 Peking University Peoples Hosp... More >>ital, Beijing, Beijing, 100044, China|Peking Union Medical College Hospital, Beijing, Beijing, 100730, China|Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, China|Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, 510515, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, China|The First Hospital of Jilin University, Changchun, Jilin, 130021, China|West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China|Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, 300020, China Less <<
NCT03189524 B-cell Lymphoma PHASE1 COMPLETED 2020-08-26 Beijing Cancer Hospital, Beiji... More >>ng, Beijing, 100142, China|Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China|Jiangsu Province Hospital, Nanjing, Jiangsu, 210029, China|Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, 300020, China Less <<
NCT04052854 Waldenstr?m Macroglobulinemia NO_LONGER_AVAILABLE - Eisenhower Desert Cardiology C... More >>enter, Rancho Mirage, California, 92270, United States|Sansum Clinic and Ridley Tree Cancer Center, Santa Barbara, California, 93105, United States|Maryland Oncology Hematology, Pa, Columbia, Maryland, 21044, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89169, United States|Morristown Medical Center, Morristown, New Jersey, 07960, United States|Icahn School of Medicine At Mount Sinai, New York, New York, 10029, United States|Clinical Research Alliance, Inc, Westbury, New York, 11590, United States|Texas Oncology Austin Midtown, Round Rock, Texas, 78681, United States|Texas Oncology Tyler Longview, Tyler, Texas, 75702, United States Less <<
NCT05320575 HLH PHASE3 COMPLETED 2023-08-01 Beijing Friendship Hospital, C... More >>apital Medical University, Beijing, China Less <<
NCT03846427 Marginal Zone Lymphoma|MZL PHASE2 COMPLETED 2022-05-04 Clinical Research Alliance, In... More >>c, Westbury, New York, 11590, United States|The Charlotte Mecklenburg Hospital Authority, Charlotte, North Carolina, 28203, United States|Canberra Hospital, Garran, Australian Capital Territory, 2605, Australia|Concord Repatriation General Hospital, Concord, New South Wales, 2139, Australia|The Saint George Hospital Kogarah, Kogarah, New South Wales, 2217, Australia|Princess Alexandra Hospital, Brisbane, Queensland, 4102, Australia|Flinders Medical Centre, Bedford PK, South Australia, 5042, Australia|Box Hill Hospital, Box Hill, Victoria, 3128, Australia|Monash Health, Clayton, Victoria, 3168, Australia|Peninsula Private Hospital, Frankston, Victoria, 3199, Australia|Peking University Third Hospital, Beijing, Beijing, 100000, China|Henan Cancer Hospital, Zhengzhou, Henan, 450000, China|Institute of Hematology and Hospital of Blood Disease, Tianjin, Tianjin, 300020, China|The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310003, China|University Hospital Vinohrady Hematology Department, Prague, 10034, Czechia|Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux, 33076, France|Hopital de La Conception Aphm, Marseille Cedex, 13005, France|Hopital Saint Louis, Paris, 75010, France|Chu Hopital Lyon Sud, PierreBenite, 69495, France|Policlinico Sorsola Malpighi, Aou Di Bologna, Bologna, 40138, Italy|Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, 20162, Italy|Universita Degli Studi Di Modena Azienda Ospedaliere Policlinco, Modena, 41124, Italy|Azienda Ospedaliera S Maria Di Terni, Terni, 05100, Italy|Ao Citta Della Salute E Della Scienza Di Torino Presidio O, Torino, 10126, Italy|Severance Hospital Yonsei University Health System, Seoul, Seoul Teugbyeolsi, 03722, Korea, Republic of|Auckland City Hospital, Auckland, 1023, New Zealand|North Shore Hospital, Takapuna, 0622, New Zealand|Beatson West of Scotland Cancer Centre, Glasgow, G12 0YN, United Kingdom|The Christie Hospital, Greater Manchester, M20 4BX, United Kingdom|University College Hospital, London, NW1 2PG, United Kingdom|Royal Marsden Hospital, London, SW3 6JJ, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.12mL

0.42mL

0.21mL

10.60mL

2.12mL

1.06mL

21.21mL

4.24mL

2.12mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories